Medica Depot carries both products for licensed professionals who want to buy Saypha online, but Croma Saypha Volume and Saypha Rich are designed for very different treatment goals. Saypha Volume provides structural correction, while Saypha Rich focuses on hydration and skin quality.
Those differences become clearer when the products are compared by formulation, strength, presentation, clinical application, duration, and expected visual changes. The Croma Saypha Volume vs Saypha Rich comparison also considers practitioner reception and how each product may fit within a treatment plan.
Key Takeaways
- Croma Saypha Volume is a cross-linked HA filler intended for structural correction, while Saypha Rich combines non-cross-linked HA with glycerol for hydration and skin-quality treatments.
- Their different formulations produce very different handling characteristics: Volume is designed for deeper placement and support, while Rich is a softer product used more superficially.
- Product selection depends primarily on the treatment objective rather than choosing one as a substitute for the other.
About: Medica Depot is your trusted all-in-one supplier, offering a range of high-quality medical injectables and supplies. We offer a worry-free experience in searching for the best and most popular products on the market, like Saypha. Whether for health professionals, plastic surgeons, dermatologists, licensed estheticians, or other specialists, we can offer genuine, brand-name products you may need. With Medica Depot, we prioritize serving you better to improve the patient’s quality of life.
Croma Saypha Volume vs Saypha Rich: An Overview
Croma Saypha Volume and Saypha Rich belong to the same Croma-Pharma product family, but they are intended for different aesthetic objectives. Saypha Volume provides structural correction in deeper tissue planes, while Saypha Rich is designed for superficial hydration and improvement in skin quality.
The distinction affects nearly every aspect of treatment, from formulation and viscosity to injection depth, treatment schedule, and the type of change patients can expect to see.
Where Does Each Product Fit Clinically?
Saypha Volume is intended for treatment goals that require structural support. Its uses include correction of deep wrinkles and folds, restoration of cheek and cheekbone volume, contouring of the chin and jawline, and treatment of moderate to severe nasolabial folds and marionette lines.
Saypha Rich addresses a different set of concerns. It is used as a skin-quality treatment for hydration, tone, elasticity, and fine lines, including areas around the eyes and mouth. Treatment may also extend to the face, neck, and décolleté [3].
The products therefore address different priorities: Volume is used when the treatment plan calls for shape, projection, or replacement of lost volume, while Rich is intended when the focus is hydration and superficial skin improvement.
What Sets the Two Formulations Apart?
Saypha Volume contains 23 mg/ml of reinforced, cross-linked hyaluronic acid of non-animal origin. Its formulation is designed to provide viscosity and structural support when placed in deeper tissue planes. The product is also available in lidocaine-containing presentations intended to improve comfort during injection.
Saypha Rich contains 18 mg/ml of non-cross-linked hyaluronic acid combined with glycerol. Rather than creating structural volume, the formulation is designed to support hydration within the superficial dermis [3]. Glycerol contributes to the product’s water-binding properties, while the non-cross-linked HA gives Rich a different behavior from a conventional volumizing filler.
Research on non-cross-linked HA gels has also reported measurable improvements in skin hydration and mechanical properties compared with saline controls [1].
Strength, Viscosity, and Presentation Options
The difference in viscosity reflects the different roles of the two products. Croma Saypha Volume is a firmer, cohesive gel designed to maintain shape and provide support after placement, making it suitable for applications such as cheek enhancement and facial contouring.
Croma Saypha Volume Plus has a higher-viscosity presentation intended for deeper placement where greater structural correction is required.
Saypha Rich is supplied in 1 ml pre-filled syringes and has a softer, lower-viscosity consistency. Its handling characteristics are suited to superficial administration across broader treatment areas rather than concentrated structural placement.
How Long Do Results Last in the Skin?
The duration of treatment effects differs because the two products serve different purposes and use different HA formulations.
Saypha Volume’s cross-linked structure is intended to resist breakdown and maintain structural correction over time. The current product information describes results that may persist for approximately 6 to 12 months or longer, depending on formulation, treatment area, placement depth, and individual patient factors.
Saypha Rich is generally administered as a treatment course rather than as a single structural correction. An initial series typically involves three sessions spaced approximately two to three weeks apart, followed by maintenance treatments according to the patient’s response and treatment plan. Documented aesthetic improvements have been reported for up to four months in lateral canthal lines and up to six months in perioral lines [3].
The shorter maintenance cycle reflects its role as a skin-quality treatment rather than a volumizing filler.
What Do Saypha Rich Before-and-After Results Typically Show?
Saypha Rich before-and-after results are typically subtler than the changes associated with a volumizing filler. Because the product is intended to improve skin quality rather than create projection or restore significant volume, visible changes may include improved hydration, smoother texture, softened fine lines, and a more even-looking complexion.
Results also develop differently from those of Saypha Volume. Structural correction with Volume may be visible soon after treatment, while the effects associated with Rich can become more apparent across the recommended treatment course.
Setting that distinction during consultation can help patients understand why the two products should not be evaluated using the same expectations.
What Has the Industry Reception Been for Each?
Industry attention around Saypha Rich has included its regulatory positioning. Croma-Pharma reported that Saypha RICH became the first dermal filler to meet EU Medical Device Regulation requirements under Annex XVI for aesthetic treatments [3].
Discussion of Saypha Volume, meanwhile, tends to focus on its role as a structural HA filler and its handling in applications requiring deeper correction and contouring.
Because the two products are used for different purposes, practitioner feedback is most useful when considered according to the treatment being performed rather than as a direct popularity comparison. Readers looking for a broader synthesis of product and practitioner feedback can also review Saypha filler reviews.
Which Product Fits Which Treatment Goal?
Croma Saypha Volume is the more relevant option when the treatment objective involves structural correction, such as restoring cheek volume, defining facial contours, or addressing deeper folds. Saypha Rich is intended for patients whose primary concerns involve hydration, texture, elasticity, or early fine lines.
The products may also be incorporated into the same broader treatment plan when both structural correction and skin-quality improvement are appropriate. In that situation, each serves a separate function rather than replacing the other.
For clinics using both products, sourcing them through one established supplier can also simplify purchasing and inventory management.
The contents of this page are meant for licensed medical professionals. They serve informational purposes only and are not to be taken as medical advice.
Citations
[1] Duteil, Luc et al. “The Effects of a Non-crossed-linked Hyaluronic Acid Gel on the Aging Signs of the Face versus Normal Saline: A Randomized, Double-blind, Placebo-controlled, Split-faced Study.” The Journal of clinical and aesthetic dermatology vol. 16,2 (2023): 29-36.
[2] Frank, Konstantin et al. “The Safety Profile of a Portfolio of Hyaluronic Acid-Based Soft Tissue Fillers Manufactured Using MACRO Technology: A Systematic Review of Clinical Evidence.” Life (Basel, Switzerland) vol. 16,1 110. 13 Jan. 2026, doi:10.3390/life16010110
[3] Croma-Pharma GmbH. “Croma-Pharma Is the First Company Worldwide to Achieve MDR Approval in the Aesthetic Field.” Croma Pharma, 31 Oct. 2023, www.cromapharma.com/int/about-croma/press-and-downloads/croma-pharma-first-company-worldwide-to-achieve-mdr-approval-in-the-aesthetic-field/.
This content was prepared and reviewed under our editorial guidelines , which govern how we source, verify, and update clinical and product information. Every claim is checked against peer-reviewed research, manufacturer documentation, or regulatory guidance before publication.
